LoginSignup
Novartis logo

Novartis Stock

StockStock
ISIN: CH0012005267
Ticker: NOVN
CH0012005267
NOVN

Price

Historical dividends and forecast

All dividend data

Novartis has so far distributed $3.761 in 2024. The next dividend will be paid on 11.03.2025

$1.977

CHART BY

Frequently asked questions

What is Novartis's market capitalization?

The market capitalization of Novartis is $232.58B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Novartis's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Novartis is 12.43. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Novartis?

Novartis's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $8.544. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Novartis's stock?

Currently, 26 analysts cover Novartis's stock, with a consensus target price of $111.67. Analyst ratings provide insights into the stock's expected performance.

What is Novartis's revenue over the trailing twelve months?

Over the trailing twelve months, Novartis reported a revenue of $49.87B.

What is the EBITDA for Novartis?

Novartis's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $20.27B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Novartis?

Novartis has a free cash flow of $5.52B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Novartis's stock?

The 5-year beta for Novartis is 0.93. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Novartis have, and what sector and industry does it belong to?

Novartis employs approximately 76,057 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Novartis's shares?

The free float of Novartis is 1.93B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $232.58B

5Y beta

 0.93

EPS (TTM)

 $8.544

Free Float

 1.93B

P/E ratio (TTM)

 12.43

Revenue (TTM)

 $49.87B

EBITDA (TTM)

 $20.27B

Free Cashflow (TTM)

 $5.52B

Pricing

1D span
$104.45$105.44
52W span
$85.53$117.09

Analyst Ratings

The price target is $111.67 and the stock is covered by 26 analysts.

Buy

12

Hold

12

Sell

2

Information

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

76,057

Biotechnology & Drugs

Health Care

Identifier

ISIN

CH0012005267

Primary Ticker

NOVN

Knockouts

Join the conversation
Sign upLogin